Scarica l'app Stockscreener
12.70
1.85%
-0.24
Dopo l'orario di chiusura:
12.75
0.05
+0.39%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché OCUL Giù?
Forum
Previsione
Precedente Chiudi:
$12.94
Aprire:
$12.95
Volume 24 ore:
2.79M
Relative Volume:
1.18
Capitalizzazione di mercato:
$2.21B
Reddito:
$61.10M
Utile/perdita netta:
$-138.36M
Rapporto P/E:
-9.4074
EPS:
-1.35
Flusso di cassa netto:
$-90.59M
1 W Prestazione:
+1.44%
1M Prestazione:
+2.83%
6M Prestazione:
+95.38%
1 anno Prestazione:
+50.65%
Intervallo 1D:
$12.41
$13.24
Intervallo di 1 settimana:
$12.02
$13.24
Portata 52W:
$5.80
$13.24
Ocular Therapeutix Inc Stock (OCUL) Company Profile
Nome
Ocular Therapeutix Inc
Settore
Industria
Telefono
781-357-4000
Indirizzo
15 CROSBY DRIVE, BEDFORD, MA
Confronta OCUL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OCUL
Ocular Therapeutix Inc
|
12.70 | 2.21B | 61.10M | -138.36M | -90.59M | -1.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Ocular Therapeutix Inc Stock (OCUL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-08 | Iniziato | William Blair | Outperform |
| 2025-03-18 | Iniziato | RBC Capital Mkts | Outperform |
| 2025-03-11 | Iniziato | Needham | Buy |
| 2024-10-16 | Iniziato | Scotiabank | Sector Outperform |
| 2024-06-20 | Aggiornamento | TD Cowen | Hold → Buy |
| 2024-05-31 | Ripresa | Piper Sandler | Overweight |
| 2024-02-09 | Iniziato | BofA Securities | Buy |
| 2023-04-21 | Iniziato | Robert W. Baird | Outperform |
| 2022-08-10 | Ripresa | Berenberg | Buy |
| 2021-08-10 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2020-12-28 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2020-12-17 | Iniziato | Berenberg | Buy |
| 2020-11-13 | Reiterato | Raymond James | Strong Buy |
| 2020-08-10 | Reiterato | H.C. Wainwright | Buy |
| 2020-03-03 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2019-05-21 | Downgrade | Cowen | Outperform → Market Perform |
| 2019-05-21 | Reiterato | H.C. Wainwright | Buy |
| 2019-05-21 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2018-12-03 | Reiterato | Cantor Fitzgerald | Overweight |
| 2018-11-15 | Iniziato | Raymond James | Strong Buy |
| 2018-09-07 | Iniziato | Piper Jaffray | Overweight |
| 2017-10-24 | Iniziato | Guggenheim | Buy |
| 2017-07-26 | Iniziato | H.C. Wainwright | Buy |
| 2017-07-12 | Reiterato | Cantor Fitzgerald | Overweight |
| 2017-06-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2017-02-10 | Iniziato | Cantor Fitzgerald | Overweight |
| 2016-11-15 | Reiterato | RBC Capital Mkts | Outperform |
| 2016-08-11 | Iniziato | JMP Securities | Mkt Outperform |
| 2016-02-17 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2015-10-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2015-08-13 | Iniziato | Morgan Stanley | Overweight |
Mostra tutto
Ocular Therapeutix Inc Borsa (OCUL) Ultime notizie
Ocular Hypertension Pipeline Insights Report DelveInsight | Santen Pharmaceutical, Nicox Ophthalmics, Inc., Allysta Pharmaceuticals, Qlaris Bio, Inc, Ripple Therapeutics, Laboratoires Thea, Ocular T - The Globe and Mail
Ocular Therapeutix stock hits 52-week high at $12.91 - Investing.com
Is Ocular Therapeutix Inc. a candidate for recovery playMarket Activity Summary & Technical Entry and Exit Alerts - Newser
Sector ETF performance correlation with Ocular Therapeutix Inc.July 2025 Macro Moves & Reliable Price Breakout Signals - Newser
Signal strength of Ocular Therapeutix Inc. stock in tech scannersQuarterly Profit Summary & High Win Rate Trade Tips - Newser
Visual analytics tools that track Ocular Therapeutix Inc. performance2025 Growth vs Value & Scalable Portfolio Growth Methods - Newser
Historical volatility pattern of Ocular Therapeutix Inc. visualizedWeekly Risk Report & Safe Entry Momentum Tips - Newser
Can Ocular Therapeutix Inc. maintain its current growth rate2025 Dividend Review & Technical Entry and Exit Tips - khodrobank.com
How to build a custom watchlist for Ocular Therapeutix Inc.Trade Ideas & Long-Term Investment Growth Plans - Newser
Statistical indicators supporting Ocular Therapeutix Inc.’s strengthQuarterly Earnings Report & High Accuracy Trade Alerts - Newser
How much upside does Ocular Therapeutix Inc. haveJuly 2025 Trade Ideas & Safe Swing Trade Setups - khodrobank.com
EURETINA Innovation Spotlight kickstarts the 2025 Congress - Modern Retina
Ocular Therapeutix Inc. stock retracement – recovery analysis2025 Geopolitical Influence & Smart Money Movement Tracker - Newser
What are Ocular Therapeutix Inc.’s technical support levelsJuly 2025 Technicals & AI Powered Market Entry Ideas - khodrobank.com
What to do if you’re stuck in Ocular Therapeutix Inc.Quarterly Profit Report & Risk Controlled Swing Alerts - Newser
How to build a dashboard for Ocular Therapeutix Inc. stockJuly 2025 Volume & Community Verified Trade Signals - Newser
Will Ocular Therapeutix Inc. benefit from macro trends2025 Volatility Report & Weekly High Conviction Trade Ideas - Newser
Will Ocular Therapeutix Inc. outperform the marketMarket Movers & High Accuracy Buy Signal Tips - Newser
Should I buy Ocular Therapeutix Inc. stock now2025 Valuation Update & Long Hold Capital Preservation Plans - khodrobank.com
Retail Surge: Can Ocular Therapeutix Inc. sustain earnings growth2025 EndofYear Setup & Short-Term Trading Alerts - خودرو بانک
Will Ocular Therapeutix Inc. bounce back from current support2025 Top Decliners & Growth Focused Stock Reports - Newser
Technical analysis overview for Ocular Therapeutix Inc. stockWeekly Trade Analysis & Capital Efficiency Focused Ideas - Newser
Chart based analysis of Ocular Therapeutix Inc. trendsJuly 2025 Technicals & Expert Curated Trade Setup Alerts - Newser
Best data tools to analyze Ocular Therapeutix Inc. stockJuly 2025 Review & Technical Pattern Recognition Alerts - Newser
How hedge fund analytics apply to Ocular Therapeutix Inc. stockDollar Strength & Fast Gain Stock Trading Tips - Newser
Ocular Therapeutix Inc. Tests 50 Day MA After Sharp Decline2025 Market Sentiment & Safe Entry Zone Identification - beatles.ru
Don't Ignore The Insider Selling In Ocular Therapeutix - 富途牛牛
Ocular Therapeutix Inc. stock trend outlook and recovery pathWeekly Investment Report & Weekly Top Gainers Alerts - Newser
Visual trend scoring systems applied to Ocular Therapeutix Inc.Layoff News & Smart Investment Allocation Insights - Newser
Ocular Therapeutix Inc Azioni (OCUL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Ocular Therapeutix Inc Azioni (OCUL) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Kaiser Peter | Chief Development Officer |
Aug 25 '25 |
Sale |
12.04 |
3,011 |
36,252 |
204,093 |
| Nayak Sanjay | Chief Strategy Officer |
Aug 25 '25 |
Sale |
12.04 |
1,885 |
22,695 |
279,738 |
| Heier Jeffrey S. | Chief Scientific Officer |
Aug 25 '25 |
Sale |
12.04 |
3,063 |
36,879 |
259,911 |
| Dugel Pravin | See Remarks |
Aug 25 '25 |
Sale |
12.04 |
21,494 |
258,788 |
3,227,244 |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):